Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib von D'souza, Anishka, Shishedo, Stephanie, Spicer, Darcy V., Welter, Lisa, Jiang, Yuanfei, Hyman, David Michael, Solit, David B., Ma, Cynthia X., Bose, Ron, Cutler, Richard E., Eli, Lisa, Hicks, James B, Kuhn, Peter, Lu, Janice M.

Volltext